HEADER TRANSFERASE 26-AUG-15 5DF9 TITLE CRYSTAL STRUCTURE OF PENICILLIN-BINDING PROTEIN 3 IN COMPLEX WITH TITLE 2 DEACYLATED PRODUCT OF CEFOPERAZONE COMPND MOL_ID: 1; COMPND 2 MOLECULE: CELL DIVISION PROTEIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 35-579; COMPND 5 SYNONYM: PENICILLIN-BINDING PROTEIN 3,PSEUDOMONAS AERUGINOSA GENOME COMPND 6 ASSEMBLY PAE221; COMPND 7 EC: 2.4.1.129; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PSEUDOMONAS AERUGINOSA; SOURCE 3 ORGANISM_TAXID: 287; SOURCE 4 GENE: PBPB, FTSI_2, ERS445055_04698, PAE221_03076, YQ19_27590; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS CEFOPERAZONE, BETA-LACTAM ANTIBIOTICS, ACYL-ENZYME COMPLEX, DE- KEYWDS 2 ACYLATION, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.REN,J.E.NETTLESHIP,A.MALES,D.I.STUART,R.J.OWENS REVDAT 3 10-JAN-24 5DF9 1 REMARK REVDAT 2 10-FEB-16 5DF9 1 JRNL REVDAT 1 13-JAN-16 5DF9 0 JRNL AUTH J.REN,J.E.NETTLESHIP,A.MALES,D.I.STUART,R.J.OWENS JRNL TITL CRYSTAL STRUCTURES OF PENICILLIN-BINDING PROTEIN 3 IN JRNL TITL 2 COMPLEXES WITH AZLOCILLIN AND CEFOPERAZONE IN BOTH ACYLATED JRNL TITL 3 AND DEACYLATED FORMS. JRNL REF FEBS LETT. V. 590 288 2016 JRNL REFN ISSN 0014-5793 JRNL PMID 26823174 JRNL DOI 10.1002/1873-3468.12054 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.7.0032 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.97 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 15029 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.205 REMARK 3 R VALUE (WORKING SET) : 0.202 REMARK 3 FREE R VALUE : 0.249 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 786 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.77 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1110 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.49 REMARK 3 BIN R VALUE (WORKING SET) : 0.3290 REMARK 3 BIN FREE R VALUE SET COUNT : 57 REMARK 3 BIN FREE R VALUE : 0.4040 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3886 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 54 REMARK 3 SOLVENT ATOMS : 21 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 75.16 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.43000 REMARK 3 B22 (A**2) : -3.26000 REMARK 3 B33 (A**2) : 4.41000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.75000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.352 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.287 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 31.791 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.950 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.931 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4016 ; 0.004 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 3919 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5451 ; 0.903 ; 1.982 REMARK 3 BOND ANGLES OTHERS (DEGREES): 8982 ; 0.669 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 508 ; 4.858 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 169 ;32.469 ;23.136 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 660 ;12.857 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 37 ;11.152 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 610 ; 0.049 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4570 ; 0.003 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 907 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2035 ; 2.987 ;13.385 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2034 ; 2.978 ;13.385 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2542 ; 4.667 ;22.586 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2543 ; 4.667 ;22.588 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1981 ; 3.664 ;15.059 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1981 ; 3.662 ;15.058 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 2910 ; 5.892 ;24.826 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 4351 ; 8.339 ;61.074 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 4349 ; 8.337 ;61.069 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 3 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 1 A 150 REMARK 3 ORIGIN FOR THE GROUP (A): 5.5516 18.8449 -16.3232 REMARK 3 T TENSOR REMARK 3 T11: 0.0642 T22: 0.1792 REMARK 3 T33: 0.5081 T12: 0.0195 REMARK 3 T13: -0.0723 T23: -0.0178 REMARK 3 L TENSOR REMARK 3 L11: 6.4255 L22: 0.8378 REMARK 3 L33: 0.8599 L12: 2.2057 REMARK 3 L13: -1.1870 L23: -0.1894 REMARK 3 S TENSOR REMARK 3 S11: 0.3758 S12: -0.0516 S13: -0.2908 REMARK 3 S21: 0.1650 S22: -0.0335 S23: -0.2583 REMARK 3 S31: 0.0056 S32: -0.1295 S33: -0.3423 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 151 A 265 REMARK 3 ORIGIN FOR THE GROUP (A): -16.0134 9.9983 -15.3800 REMARK 3 T TENSOR REMARK 3 T11: 0.2375 T22: 0.2742 REMARK 3 T33: 0.1204 T12: -0.0345 REMARK 3 T13: 0.0296 T23: 0.0466 REMARK 3 L TENSOR REMARK 3 L11: 2.6593 L22: 1.5440 REMARK 3 L33: 0.8501 L12: 1.8584 REMARK 3 L13: 1.3852 L23: 1.1199 REMARK 3 S TENSOR REMARK 3 S11: -0.0175 S12: -0.0513 S13: 0.2069 REMARK 3 S21: 0.0241 S22: -0.0271 S23: 0.0067 REMARK 3 S31: 0.0536 S32: 0.0633 S33: 0.0446 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 266 A 561 REMARK 3 ORIGIN FOR THE GROUP (A): -42.7221 -4.0207 -27.6867 REMARK 3 T TENSOR REMARK 3 T11: 0.1858 T22: 0.1357 REMARK 3 T33: 0.2087 T12: -0.0220 REMARK 3 T13: 0.0295 T23: -0.0450 REMARK 3 L TENSOR REMARK 3 L11: 2.3846 L22: 0.8364 REMARK 3 L33: 0.5500 L12: 0.4021 REMARK 3 L13: 0.7337 L23: 0.4999 REMARK 3 S TENSOR REMARK 3 S11: 0.0300 S12: 0.1171 S13: -0.0387 REMARK 3 S21: 0.0060 S22: -0.1629 S23: 0.2832 REMARK 3 S31: -0.0313 S32: 0.0588 S33: 0.1329 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 5DF9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 27-AUG-15. REMARK 100 THE DEPOSITION ID IS D_1000213118. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-JAN-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 9.5 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I02 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97960 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15866 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : 0.09200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.80 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.70 REMARK 200 R MERGE FOR SHELL (I) : 0.72200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 5DF8 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.10 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.33 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.26 M (NH4)2SO4; 0.1 M CHES PH 9.5; REMARK 280 0.2 M NACL, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 294K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 88.44200 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 20.63200 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 88.44200 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 20.63200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 600 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23170 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -21.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 16 REMARK 465 ALA A 17 REMARK 465 HIS A 18 REMARK 465 HIS A 19 REMARK 465 HIS A 20 REMARK 465 HIS A 21 REMARK 465 HIS A 22 REMARK 465 HIS A 23 REMARK 465 SER A 24 REMARK 465 SER A 25 REMARK 465 GLY A 26 REMARK 465 LEU A 27 REMARK 465 GLU A 28 REMARK 465 VAL A 29 REMARK 465 LEU A 30 REMARK 465 PHE A 31 REMARK 465 GLN A 32 REMARK 465 GLY A 33 REMARK 465 PRO A 34 REMARK 465 ASP A 35 REMARK 465 LEU A 36 REMARK 465 HIS A 37 REMARK 465 VAL A 38 REMARK 465 ILE A 39 REMARK 465 ASP A 40 REMARK 465 HIS A 41 REMARK 465 ASP A 42 REMARK 465 PHE A 43 REMARK 465 LEU A 44 REMARK 465 LYS A 45 REMARK 465 GLY A 46 REMARK 465 GLN A 47 REMARK 465 GLY A 48 REMARK 465 ASP A 49 REMARK 465 ALA A 50 REMARK 465 ARG A 51 REMARK 465 SER A 52 REMARK 465 THR A 562 REMARK 465 ALA A 563 REMARK 465 THR A 564 REMARK 465 GLU A 565 REMARK 465 GLN A 566 REMARK 465 GLN A 567 REMARK 465 GLN A 568 REMARK 465 VAL A 569 REMARK 465 ASN A 570 REMARK 465 ALA A 571 REMARK 465 ALA A 572 REMARK 465 PRO A 573 REMARK 465 ALA A 574 REMARK 465 LYS A 575 REMARK 465 GLY A 576 REMARK 465 GLY A 577 REMARK 465 ARG A 578 REMARK 465 GLY A 579 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 141 16.81 56.67 REMARK 500 ASP A 169 -169.84 -77.02 REMARK 500 ASP A 198 -162.14 -115.40 REMARK 500 THR A 267 -169.61 -123.49 REMARK 500 ASN A 275 94.62 53.23 REMARK 500 PRO A 320 30.59 -95.83 REMARK 500 ARG A 395 -70.42 71.70 REMARK 500 ASN A 427 41.74 -93.16 REMARK 500 VAL A 493 83.90 -65.77 REMARK 500 ASP A 515 83.66 -158.41 REMARK 500 LYS A 529 16.60 -156.52 REMARK 500 ALA A 530 56.27 -166.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 59J A 603 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 604 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5DF8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PENICILLIN-BINDING PROTEIN 3 FROM PSEUDOMONAS REMARK 900 AERUGINOSA IN COMPLEX WITH CEFOPERAZONE DBREF 5DF9 A 35 579 UNP Q51504 Q51504_PSEAI 35 579 SEQADV 5DF9 MET A 16 UNP Q51504 INITIATING METHIONINE SEQADV 5DF9 ALA A 17 UNP Q51504 EXPRESSION TAG SEQADV 5DF9 HIS A 18 UNP Q51504 EXPRESSION TAG SEQADV 5DF9 HIS A 19 UNP Q51504 EXPRESSION TAG SEQADV 5DF9 HIS A 20 UNP Q51504 EXPRESSION TAG SEQADV 5DF9 HIS A 21 UNP Q51504 EXPRESSION TAG SEQADV 5DF9 HIS A 22 UNP Q51504 EXPRESSION TAG SEQADV 5DF9 HIS A 23 UNP Q51504 EXPRESSION TAG SEQADV 5DF9 SER A 24 UNP Q51504 EXPRESSION TAG SEQADV 5DF9 SER A 25 UNP Q51504 EXPRESSION TAG SEQADV 5DF9 GLY A 26 UNP Q51504 EXPRESSION TAG SEQADV 5DF9 LEU A 27 UNP Q51504 EXPRESSION TAG SEQADV 5DF9 GLU A 28 UNP Q51504 EXPRESSION TAG SEQADV 5DF9 VAL A 29 UNP Q51504 EXPRESSION TAG SEQADV 5DF9 LEU A 30 UNP Q51504 EXPRESSION TAG SEQADV 5DF9 PHE A 31 UNP Q51504 EXPRESSION TAG SEQADV 5DF9 GLN A 32 UNP Q51504 EXPRESSION TAG SEQADV 5DF9 GLY A 33 UNP Q51504 EXPRESSION TAG SEQADV 5DF9 PRO A 34 UNP Q51504 EXPRESSION TAG SEQRES 1 A 564 MET ALA HIS HIS HIS HIS HIS HIS SER SER GLY LEU GLU SEQRES 2 A 564 VAL LEU PHE GLN GLY PRO ASP LEU HIS VAL ILE ASP HIS SEQRES 3 A 564 ASP PHE LEU LYS GLY GLN GLY ASP ALA ARG SER VAL ARG SEQRES 4 A 564 HIS ILE ALA ILE PRO ALA HIS ARG GLY LEU ILE THR ASP SEQRES 5 A 564 ARG ASN GLY GLU PRO LEU ALA VAL SER THR PRO VAL THR SEQRES 6 A 564 THR LEU TRP ALA ASN PRO LYS GLU LEU MET THR ALA LYS SEQRES 7 A 564 GLU ARG TRP PRO GLN LEU ALA ALA ALA LEU GLY GLN ASP SEQRES 8 A 564 THR LYS LEU PHE ALA ASP ARG ILE GLU GLN ASN ALA GLU SEQRES 9 A 564 ARG GLU PHE ILE TYR LEU VAL ARG GLY LEU THR PRO GLU SEQRES 10 A 564 GLN GLY GLU GLY VAL ILE ALA LEU LYS VAL PRO GLY VAL SEQRES 11 A 564 TYR SER ILE GLU GLU PHE ARG ARG PHE TYR PRO ALA GLY SEQRES 12 A 564 GLU VAL VAL ALA HIS ALA VAL GLY PHE THR ASP VAL ASP SEQRES 13 A 564 ASP ARG GLY ARG GLU GLY ILE GLU LEU ALA PHE ASP GLU SEQRES 14 A 564 TRP LEU ALA GLY VAL PRO GLY LYS ARG GLN VAL LEU LYS SEQRES 15 A 564 ASP ARG ARG GLY ARG VAL ILE LYS ASP VAL GLN VAL THR SEQRES 16 A 564 LYS ASN ALA LYS PRO GLY LYS THR LEU ALA LEU SER ILE SEQRES 17 A 564 ASP LEU ARG LEU GLN TYR LEU ALA HIS ARG GLU LEU ARG SEQRES 18 A 564 ASN ALA LEU LEU GLU ASN GLY ALA LYS ALA GLY SER LEU SEQRES 19 A 564 VAL ILE MET ASP VAL LYS THR GLY GLU ILE LEU ALA MET SEQRES 20 A 564 THR ASN GLN PRO THR TYR ASN PRO ASN ASN ARG ARG ASN SEQRES 21 A 564 LEU GLN PRO ALA ALA MET ARG ASN ARG ALA MET ILE ASP SEQRES 22 A 564 VAL PHE GLU PRO GLY SER THR VAL LYS PRO PHE SER MET SEQRES 23 A 564 SER ALA ALA LEU ALA SER GLY ARG TRP LYS PRO SER ASP SEQRES 24 A 564 ILE VAL ASP VAL TYR PRO GLY THR LEU GLN ILE GLY ARG SEQRES 25 A 564 TYR THR ILE ARG ASP VAL SER ARG ASN SER ARG GLN LEU SEQRES 26 A 564 ASP LEU THR GLY ILE LEU ILE LYS SER SER ASN VAL GLY SEQRES 27 A 564 ILE SER LYS ILE ALA PHE ASP ILE GLY ALA GLU SER ILE SEQRES 28 A 564 TYR SER VAL MET GLN GLN VAL GLY LEU GLY GLN ASP THR SEQRES 29 A 564 GLY LEU GLY PHE PRO GLY GLU ARG VAL GLY ASN LEU PRO SEQRES 30 A 564 ASN HIS ARG LYS TRP PRO LYS ALA GLU THR ALA THR LEU SEQRES 31 A 564 ALA TYR GLY TYR GLY LEU SER VAL THR ALA ILE GLN LEU SEQRES 32 A 564 ALA HIS ALA TYR ALA ALA LEU ALA ASN ASP GLY LYS SER SEQRES 33 A 564 VAL PRO LEU SER MET THR ARG VAL ASP ARG VAL PRO ASP SEQRES 34 A 564 GLY VAL GLN VAL ILE SER PRO GLU VAL ALA SER THR VAL SEQRES 35 A 564 GLN GLY MET LEU GLN GLN VAL VAL GLU ALA GLN GLY GLY SEQRES 36 A 564 VAL PHE ARG ALA GLN VAL PRO GLY TYR HIS ALA ALA GLY SEQRES 37 A 564 LYS SER GLY THR ALA ARG LYS VAL SER VAL GLY THR LYS SEQRES 38 A 564 GLY TYR ARG GLU ASN ALA TYR ARG SER LEU PHE ALA GLY SEQRES 39 A 564 PHE ALA PRO ALA THR ASP PRO ARG ILE ALA MET VAL VAL SEQRES 40 A 564 VAL ILE ASP GLU PRO SER LYS ALA GLY TYR PHE GLY GLY SEQRES 41 A 564 LEU VAL SER ALA PRO VAL PHE SER LYS VAL MET ALA GLY SEQRES 42 A 564 ALA LEU ARG LEU MET ASN VAL PRO PRO ASP ASN LEU PRO SEQRES 43 A 564 THR ALA THR GLU GLN GLN GLN VAL ASN ALA ALA PRO ALA SEQRES 44 A 564 LYS GLY GLY ARG GLY HET SO4 A 601 5 HET SO4 A 602 5 HET 59J A 603 38 HET GOL A 604 6 HETNAM SO4 SULFATE ION HETNAM 59J (2R,5R)-2-[(R)-CARBOXY{[(2R)-2-{[(4-ETHYL-2,3- HETNAM 2 59J DIOXOPIPERAZIN-1-YL)CARBONYL]AMINO}-2-(4- HETNAM 3 59J HYDROXYPHENYL)ACETYL]AMINO}METHYL]-5-METHYL-5,6- HETNAM 4 59J DIHYDRO-2H-1,3-THIAZINE-4-CARBOXYLIC ACID HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 SO4 2(O4 S 2-) FORMUL 4 59J C23 H27 N5 O9 S FORMUL 5 GOL C3 H8 O3 FORMUL 6 HOH *21(H2 O) HELIX 1 AA1 ASN A 85 MET A 90 1 6 HELIX 2 AA2 THR A 91 GLU A 94 5 4 HELIX 3 AA3 ARG A 95 LEU A 103 1 9 HELIX 4 AA4 ASP A 106 ASN A 117 1 12 HELIX 5 AA5 THR A 130 ALA A 139 1 10 HELIX 6 AA6 ALA A 157 VAL A 160 5 4 HELIX 7 AA7 VAL A 161 GLY A 166 1 6 HELIX 8 AA8 GLU A 176 PHE A 182 1 7 HELIX 9 AA9 PHE A 182 ALA A 187 1 6 HELIX 10 AB1 ASP A 224 ASN A 242 1 19 HELIX 11 AB2 PRO A 278 ARG A 282 5 5 HELIX 12 AB3 ASN A 283 ASP A 288 1 6 HELIX 13 AB4 PRO A 292 THR A 295 5 4 HELIX 14 AB5 VAL A 296 SER A 307 1 12 HELIX 15 AB6 LEU A 342 LYS A 348 1 7 HELIX 16 AB7 SER A 350 GLY A 362 1 13 HELIX 17 AB8 GLY A 362 VAL A 373 1 12 HELIX 18 AB9 PRO A 398 TYR A 407 1 10 HELIX 19 AC1 THR A 414 ASN A 427 1 14 HELIX 20 AC2 SER A 450 ALA A 467 1 18 HELIX 21 AC3 VAL A 471 GLN A 475 5 5 HELIX 22 AC4 PHE A 533 SER A 538 1 6 HELIX 23 AC5 SER A 538 MET A 553 1 16 SHEET 1 AA1 3 ARG A 54 ILE A 58 0 SHEET 2 AA1 3 GLY A 191 VAL A 195 -1 O VAL A 195 N ARG A 54 SHEET 3 AA1 3 VAL A 209 LYS A 211 -1 O LYS A 211 N LYS A 192 SHEET 1 AA2 3 ILE A 123 LEU A 129 0 SHEET 2 AA2 3 PRO A 72 ALA A 84 -1 N THR A 80 O LEU A 129 SHEET 3 AA2 3 VAL A 145 PHE A 154 -1 O GLU A 150 N VAL A 79 SHEET 1 AA3 4 ILE A 123 LEU A 129 0 SHEET 2 AA3 4 PRO A 72 ALA A 84 -1 N THR A 80 O LEU A 129 SHEET 3 AA3 4 ILE A 65 THR A 66 -1 N ILE A 65 O LEU A 73 SHEET 4 AA3 4 LEU A 219 ALA A 220 1 O LEU A 219 N THR A 66 SHEET 1 AA4 2 GLY A 188 VAL A 189 0 SHEET 2 AA4 2 LYS A 214 PRO A 215 -1 O LYS A 214 N VAL A 189 SHEET 1 AA5 5 ILE A 259 GLN A 265 0 SHEET 2 AA5 5 ALA A 246 ASP A 253 -1 N ILE A 251 O ALA A 261 SHEET 3 AA5 5 ILE A 518 ASP A 525 -1 O ASP A 525 N ALA A 246 SHEET 4 AA5 5 TYR A 498 ALA A 511 -1 N GLY A 509 O MET A 520 SHEET 5 AA5 5 ALA A 482 VAL A 491 -1 N LYS A 484 O ALA A 508 SHEET 1 AA6 2 ILE A 315 ASP A 317 0 SHEET 2 AA6 2 GLN A 339 ASP A 341 -1 O LEU A 340 N VAL A 316 SHEET 1 AA7 2 THR A 322 ILE A 325 0 SHEET 2 AA7 2 TYR A 328 ARG A 331 -1 O TYR A 328 N ILE A 325 SHEET 1 AA8 2 LYS A 430 SER A 431 0 SHEET 2 AA8 2 VAL A 446 GLN A 447 -1 O VAL A 446 N SER A 431 CISPEP 1 GLN A 265 PRO A 266 0 2.62 CISPEP 2 TYR A 319 PRO A 320 0 -1.38 CISPEP 3 ALA A 511 PRO A 512 0 -6.26 CISPEP 4 LEU A 560 PRO A 561 0 -7.70 SITE 1 AC1 3 ARG A 387 VAL A 388 GLY A 389 SITE 1 AC2 2 LYS A 490 LYS A 529 SITE 1 AC3 18 ASN A 275 SER A 294 VAL A 333 SER A 349 SITE 2 AC3 18 ASN A 351 THR A 404 TYR A 407 TYR A 409 SITE 3 AC3 18 SER A 485 GLY A 486 THR A 487 ARG A 489 SITE 4 AC3 18 TYR A 498 TYR A 503 TYR A 532 PHE A 533 SITE 5 AC3 18 GLY A 534 GLY A 535 SITE 1 AC4 5 GLY A 247 SER A 248 ARG A 284 PHE A 290 SITE 2 AC4 5 ASP A 525 CRYST1 176.884 41.264 87.786 90.00 117.42 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005653 0.000000 0.002933 0.00000 SCALE2 0.000000 0.024234 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012833 0.00000